Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
WEDNESDAY, June 21, 2023 (HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration. In aContinue Reading